Cyclosporine Ophthalmic Ointment Manufacturer
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract with the Department of Defense Medical Supply Chain Pharmacy FSA involves the manufacture and supply of Cyclosporine Ophthalmic Ointment for primes delivering DLA supply contracts. The contractor is responsible for producing an ointment containing 0.2% Cyclosporine per gram, filling and sealing 3.5 gram sterile tubes, and packaging these units in sets of six tubes per package. The manufacturer must ensure all finished pharmaceutical packages comply with Medical Marking Standard No. 1, RP001 DLA Packaging Requirements, MIL-STD-2073-1E, and Special Packaging Instructions MPWN00001. This opportunity falls under NAICS code 325412 and has a response deadline of October 5, 2026.
General Info
Place of Performance
USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-5296.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
CYCLOSPORINE OPHTHALMI
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
